Transport

Spinouts working on ketamine-based therapeutics, regenerative medicines for dogs and better sleep are among those that caught our eye this month.

The global food system is creaking — creating an impetus for global agriculture companies to invest in new solutions. Corporates took part in agtech deals worth a record $18bn last year. But are they investing fast enough?

Access Industries, Pfizer and SR One were among the investors in a $125m round for Nimbus Therapeutics while Aerwins agreed a reverse takeover.

Alphabet led a $1bn round for its Verily subsidiary while Kimco Realty and The Silverman Group were part of Gotham Greens’ $310m series E.

Corporates have dramatically slowed down the rate at which they invest in startups, except in these two sectors.

Investment is building again in the sector after a lull, but big companies are hedging their bets on which type of aircraft will work best.

Hitachi grows its cell therapy portfolio, SoftBank slims down in India and Foresight Williams backs ID tags for diamonds.

Lab-grown milk is becoming commercially viable — and studies have shown that consumers aren’t averse to it. So, is it time for corporate investors to back these startups?

SHV and DELA took part in an $80m round for Lightyear while Tata Sons provided $40m in funding for Tata 1mg.

The move comes as Schenker Ventures seeks to further expand its investment team

These are the 55 women working in corporate venturing function across the DACH region — and how they got there.